Insider Selling: Quantum-Si (NASDAQ:QSI) CEO Sells $10,083.67 in Stock

Quantum-Si Incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 12,149 shares of the business’s stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $0.83, for a total transaction of $10,083.67. Following the transaction, the chief executive officer owned 3,859,847 shares of the company’s stock, valued at $3,203,673.01. This represents a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Jeffrey Alan Hawkins also recently made the following trade(s):

• On Friday, March 20th, Jeffrey Alan Hawkins sold 11,628 shares of Quantum-Si stock. The shares were sold at an average price of $0.85, for a total transaction of $9,883.80.

Quantum-Si Stock Performance

Shares of QSI opened at $0.76 on Friday. The business’s 50-day moving average is $1.01 and its two-hundred day moving average is $1.35. The company has a market capitalization of $165.33 million, a P/E ratio of -1.47 and a beta of 3.00. Quantum-Si Incorporated has a fifty-two week low of $0.76 and a fifty-two week high of $3.10.

Quantum-Si (NASDAQ:QSI) last issued its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.06. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%.The business had revenue of $0.45 million during the quarter, compared to analysts’ expectations of $0.76 million. Analysts forecast that Quantum-Si Incorporated will post -0.65 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Canaccord Genuity Group lowered their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday, March 4th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quantum-Si in a report on Monday, December 29th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $3.25.

Hedge Funds Weigh In On Quantum-Si

Several institutional investors and hedge funds have recently modified their holdings of the business. Virtu Financial LLC acquired a new position in Quantum-Si in the 4th quarter worth about $262,000. Invesco Ltd. grew its holdings in Quantum-Si by 36.2% in the fourth quarter. Invesco Ltd. now owns 402,821 shares of the company’s stock valued at $443,000 after purchasing an additional 107,093 shares during the period. XTX Topco Ltd grew its holdings in Quantum-Si by 206.9% in the fourth quarter. XTX Topco Ltd now owns 461,982 shares of the company’s stock valued at $508,000 after purchasing an additional 311,450 shares during the period. Quadrature Capital Ltd purchased a new stake in shares of Quantum-Si in the fourth quarter valued at approximately $305,000. Finally, Barclays PLC increased its position in shares of Quantum-Si by 21.8% in the fourth quarter. Barclays PLC now owns 269,415 shares of the company’s stock valued at $296,000 after buying an additional 48,205 shares in the last quarter. Hedge funds and other institutional investors own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.